New therapeutic strategies for type 2 diabetes : small molecule approaches /

New therapeutic strategies for type 2 diabetes : small molecule approaches /

PSZJBL

Bibliographic Details
Main Authors:	Jones, Robert M., Royal Society of Chemistry (Great Britain)
Format:
Language:	eng
Published:	New York : Royal Society of Chemistry, 2012
Subjects:	Diabetes Drug Discovery

Similar Items

The small molecule AUTEN-99 (autophagy enhancer-99) prevents the progression of neurodegenerative symptoms
by: Kovács, Tibor, et al.
Published: (2017)

Tissue resident memory T cells in the human conjunctiva and immune signatures in human dry eye disease
by: Bose, Tanima, et al.
Published: (2017)

Contribution of high-content imaging technologies to the development of anti-infective drugs
by: Ang, Michelle Lay Teng, et al.
Published: (2017)

Tuberculosis : laboratory diagnosis and treatment strategies /
by: McHugh, Timothy D. (Timothy Daniel)
Published: (c201)

Identification and structural characterization of small molecule fragments targeting Zika virus NS2B-NS3 protease
by: Quek, Jun Ping, et al.
Published: (2020)

Strategies for increasing frataxin expression in Friedreich's ataxia: modulation of the epigenome and proteome
by: Quinlan, R
Published: (2021)

Structure-based drug discovery : an overview /
by: Hubbard, Roderick E., et al.
Published: (2006)

Case studies in modern drug discovery and development /
by: Huang, Xianhai, et al.
Published: (c201)

New frontiers in chemical biology : enabling drug discovery /
by: Bunnage, Mark E., et al.
Published: (c201)

Hydration effects on the efficacy of the Epidermal growth factor receptor kinase inhibitor afatinib
by: Kannan, Srinivasaraghavan, et al.
Published: (2017)

Philip's atlas of exploration /
by: 6621 Royal Geographical Society (Great Britain), et al.
Published: (1996)

Application of polymersomes in membrane protein study and drug discovery: progress, strategies, and perspectives
by: Lo, Chih Hung, et al.
Published: (2023)

A meta-analysis of bulk RNA-seq datasets identifies potential biomarkers and repurposable therapeutics against Alzheimer’s disease
by: Anika Bushra Lamisa, et al.
Published: (2024-10-01)

Physical activity and type 2 diabetes : therapeutic effects and mechanisms of action /
by: Hawley, John A., et al.
Published: (c200)

Discovery layer decisions, configurations and strategies
by: R. Schwartz
Published: (2020-07-01)

Tear-fluid-derived biomarkers of ocular complications in diabetes: a systematic review and meta-analysis
by: Mya Polkamp, et al.
Published: (2025-02-01)

The Misuse of Drugs Act : a guide for forensic scientists /
by: King, L. A., (Leslie A.), et al.
Published: (2003)

New spaces of exploration : geographies of discovery in the twentieth century /
by: Naylor, Simon, et al.
Published: (2010)

Characterizing the conformational landscape of MDM2-binding p53 peptides using molecular dynamics simulations
by: Yadahalli, Shilpa, et al.
Published: (2018)

Generation of a heteropolycyclic and sp3-rich scaffold for library synthesis from a highly diastereoselective Petasis/Diels–Alder and ROM–RCM reaction sequence
by: Flagstad, Thomas, et al.
Published: (2021)

Favorable preclinical pharmacological profile of a novel antimalarial pyrrolizidinylmethyl derivative of 4-amino-7-chloroquinoline with potent In vitro and In vivo activities
by: Basilico, Nicoletta, et al.
Published: (2023)

Mapping kinase domain resistance mechanisms for the MET receptor tyrosine kinase via deep mutational scanning
by: Gabriella O Estevam, et al.
Published: (2025-02-01)

New frontiers in scientific discovery : commemorating the life and work of zdzislaw pawlak /
by: Orlowska, E.
Published: (2007)

Handbook of solubility data for pharmaceuticals /
by: 509927 Jouyban, Abolghasem
Published: (c201)

Organic chemistry of drug degradation /
by: Min Li, et al.
Published: (2012)

PRKD2 as a novel target for targeting the diabetes–osteoporosis nexus
by: Rongjin Chen, et al.
Published: (2025-02-01)

Undeveloped Region in Target-Strategies and Potential in Antiviral Drug Discovery
by: Shaoqing Du, et al.

Exploring Quinazoline as a Scaffold for Developing Novel Therapeutics in Alzheimer’s Disease
by: Qais Abualassal, et al.
Published: (2025-01-01)

Polyamine drug discovery /
by: Woster, Patrick M., et al.
Published: (c201)

Old drugs, new challenges: reassigning drugs for cancer therapies
by: Paulina Czechowicz, et al.
Published: (2025-03-01)

Decrease of cardiovascular risk in patients with type 2 diabetes: review of the common strategies and clinical studies
by: Vladimir V. Salukhov, et al.
Published: (2018-08-01)

New materials Asia
Published: (1980)

Injectable therapy in type 2 diabetes mellitus: strategies to improve therapeutic adherence
by: Olesya Y. Gurova, et al.
Published: (2018-12-01)

Emerging drugs and targets for Alzheimer's disease /
by: Martn̕ez, Ana, 1961-, et al.
Published: (c201)

Macrocycles in drug discovery /
by: Levin, Jeremy I., et al.
Published: (2015)

Sequence-specific DNA binding agents /
by: Waring, Michael J., et al.
Published: (2006)

A study of therapeutic effects of 670 nm irradiation in different types of diabetic macular edema
by: S. Ramin, et al.
Published: (2021-02-01)

Evaluating the immunopathological effects of nigella sativa oil and its major component, thymoquinone in a streptozotocin-induces type1 diabetes rat model / Afaf Jamal Ali Hmza
by: Ali Hmza, Afaf Jamal
Published: (2013)

Cyclin-dependent kinase 12 (CDK12), human kinase domain; a Target Enabling Package
by: Dixon-Clarke, S
Published: (2018)

With No Lysine Kinase 3 (WNK3); A Target Enabling Package
by: Bullock, A
Published: (2018)